Previous Article | Next Article 
Infect Immun, March 1998, p. 899-906, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Haemophilus influenzae HtrA Protein Is a
Protective Antigen
Sheena M.
Loosmore,*
Yan-ping
Yang,
Ray
Oomen,
Jean M.
Shortreed,
Debbie C.
Coleman, and
Michel H.
Klein
Pasteur Merieux Connaught Canada Research,
North York, Ontario, Canada M2R 3T4
Received 29 September 1997/Returned for modification 4 November
1997/Accepted 30 December 1997
 |
ABSTRACT |
The htrA gene from two strains of nontypeable
Haemophilus influenzae has been cloned and sequenced, and
the encoded approximately 46-kDa HtrA proteins were found to be highly
conserved. H. influenzae HtrA has approximately 55%
identity with the Escherichia coli and Salmonella
typhimurium HtrA stress response proteins, and expression of the
H. influenzae htrA gene was inducible by high temperature.
Recombinant HtrA (rHtrA) was expressed from E. coli, and
the purified protein was found to have serine protease activity. rHtrA
was found to be very immunogenic and partially protective in both the
passive infant rat model of bacteremia and the active chinchilla model
of otitis media. Immunoblot analysis indicated that HtrA is
antigenically conserved in encapsulated and nontypeable H. influenzae species. Site-directed mutagenesis was performed on
the htrA gene to ablate the endogenous serine protease
activity of wild-type HtrA, and it was found that eight of nine
recombinant mutant proteins had no measurable residual proteolytic
activity. Two mutant proteins were tested in the animal protection
models, and one, H91A, was found to be partially protective in both
models. H91A HtrA may be a good candidate antigen for a vaccine against invasive H. influenzae type b disease and otitis media and
is currently in phase I clinical trials.
 |
INTRODUCTION |
Haemophilus influenzae is
the cause of several serious human diseases such as meningitis,
epiglottitis, septicemia, and otitis media. There are six serotypes of
H. influenzae, designated a to f, which are identified by
their capsular polysaccharides. H. influenzae type b (Hib)
was a major cause of bacterial meningitis until the introduction of
several Hib capsular polysaccharide conjugate vaccines in the 1980s
(1, 30). The other serotypes of H. influenzae are
associated with invasive disease at low frequencies, although there
appears to be an increase in disease due to these strains as the
incidence of Hib disease declines (18, 25, 34).
Nonencapsulated or nontypeable H. influenzae (NTHI) is a
major cause of otitis media (middle ear infection) in young children
and of respiratory tract infections in adults. NTHI is the second most
common bacterial cause of otitis media after Streptococcus pneumoniae and is responsible for about 25% of this disease.
Otitis media affects more than 80% of children under 6 years of age, with the peak incidence in infants under the age of two. In the United
States, the incidence of disease increased 2.5-fold between 1975 and
1990, and the causative bacteria are becoming increasingly antibiotic
resistant (17). Although otitis media is rarely life threatening, there are serious sequelae associated with the disease, including deafness and language or learning deficits, and there is
currently no vaccine.
The HtrA protein has been identified as a virulence factor in
Salmonella typhimurium, Yersinia enterocolitica
and Brucella abortus (8, 16, 20). The HtrA (or
DegP) protein of Escherichia coli has been shown to be
essential for survival of the organism at temperatures of >42°C. It
is a stress response protein belonging to the
E-dependent family of heat shock proteins (Hsps)
(7). It is not related to either the
32-regulated Hsps such as DnaK or DnaJ or the
70-regulated Hsps such as Hsp60, Hsp70, and Hsp90
(21). The S. typhimurium HtrA protein is ~89%
identical to E. coli HtrA but is not induced by heat shock,
although it is induced by oxidative stress (16).
The E. coli HtrA protein has serine protease activity
(22), and two residues of the catalytic triad have been
identified by site-directed mutagenesis (31). In this
report, we describe the cloning and sequence analysis of the
htrA genes from two strains of NTHI and the expression of
recombinant HtrA (rHtrA) in E. coli. The rHtrA protein was
shown to have serine protease activity, and site-directed mutagenesis
was performed on the three residues of the catalytic triad to ablate
the endogenous enzyme activity. The rHtrA mutant proteins were
expressed at a high yield from E. coli, and the purified
proteins were found to be highly immunogenic. Protection studies were
performed with two animal models, the passive infant rat model of
bacteremia and the active chinchilla model of otitis media.
 |
MATERIALS AND METHODS |
Recombinant DNA techniques.
Restriction endonucleases were
purchased from Boehringer Mannheim, New England Biolabs, Bethesda
Research Laboratories, and Pharmacia and were used according to the
manufacturers' specifications. Oligonucleotides were synthesized on an
Applied Biosystems Inc. model 380B DNA synthesizer and purified by
chromatography. Plasmid pUC-BgXb is a pUC8-based plasmid with
additional BglII and XbaI restriction sites in
its multiple-cloning site and was used for construction purposes. Other
recombinant DNA methods were performed as described by Sambrook et al.
(29).
Bacterial strains and media.
NTHI strains 33 and 12 are
otitis media clinical isolates kindly provided by S. Barenkamp (St.
Louis University, St. Louis, Mo.). NTHI strain LCDC2 was obtained from
the Laboratory Centre for Disease Control (Ottawa, Ontario, Canada).
Hib strain Eagan is the Pasteur Mérieux Connaught vaccine strain,
and Hib strain MinnA was a kind gift from R. Munson (Ohio State
University, Columbus). H. influenzae serotype a, c, d, e,
and f strains were purchased from the American Type Culture Collection.
H. influenzae strains were grown on Mueller-Hinton agar
(BBL) supplemented with yeast extract (0.5% [wt/vol]; Sigma), hemin
(15 µg ml
1; Difco), and NAD (15 µg ml
1;
Difco) or in brain heart infusion (BHI) broth (Difco) as described previously (14). Chocolate agar plates were purchased from
Becton Dickinson Microbiology Systems. E. coli strains were
grown in NZCYM or YT medium supplemented with 50 µg of ampicillin
ml
1 as required.
Cloning and sequencing of htrA genes.
The
construction of an NTHI strain 33 EMBL 3 chromosomal library has been
described in detail elsewhere (23). An oligonucleotide probe
(41 nucleotides) was derived from sequence information presented by
Weinstein et al. (36) and corresponded to the N terminus of
the encoded HtrA protein. The sequence of the probe is shown in Fig.
1. The probe was radiolabelled with
[
-32P]dATP, and putative genomic clones were plaque
purified three times. A 15.3-kb insert containing the NTHI strain 33 htrA gene was subcloned into pUC-BgXb, and the
htrA gene was localized to a 4.7-kb BamHI
fragment by restriction mapping and Southern blot analysis. Nested
deletion clones were generated with an Erase-a-base kit (Promega), and
sequencing was performed on the ABI model 373A DNA sequencer by using
dye terminator chemistry. The first strand sequence was obtained with
the universal forward primer, and second strand sequence was obtained
with 17- to 25-nucleotide custom primers.

View larger version (6K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide sequence and derived amino acid sequence for
the 41-nucleotide probe used in the cloning and sequencing of
htrA genes.
|
|
NTHI strain 12 chromosomal DNA was prepared as described previously
(23), and the strain 12 htrA gene was obtained by
PCR amplification with oligonucleotide primers based upon the strain 33 htrA gene sequence (Fig. 2).
PCR amplification was performed with buffer containing 10 mM Tris-HCl
(pH 8.3), 50 mM potassium chloride, and 1.5 mM magnesium chloride. Each
100 µl of reaction mixture contained 5 ng of chromosomal DNA, 1 µg
of each primer, 5 U of Amplitaq DNA polymerase (Perkin-Elmer Cetus),
and 0.2 mM concentrations of deoxynucleoside triphosphates
(Perkin-Elmer Cetus). The cycling conditions were 25 cycles of 94°C
for 1.0 min, 45°C for 2.0 min, and 72°C for 1.5 min. Three
independent reactions were performed, and amplified fragments were
cloned into pCR II (Invitrogen) and sequenced on both strands.

View larger version (6K):
[in this window]
[in a new window]
|
FIG. 2.
Oligonucleotide primers used for PCR amplification of
NTHI strain 12 DNA. The primer sequences are underlined.
|
|
Identification of active-site residues.
The NTHI HtrA
sequence was initially compared with those of the E. coli
and S. typhimurium HtrA proteins by using Intelligenetics Suite software. The sequence boundaries of the protease domain of NTHI
HtrA were defined both manually and with XALIGN (37). To
confirm the assignment of the catalytic triad residues, multiple sequence alignments and three-dimensional superimposition of mammalian and bacterial serine proteases were performed by utilizing XALIGN and
the Homology module from BIOSYM Technologies, with crystal structures
obtained from the Protein Data Bank (5).
Expression of recombinant HtrA and generation of mutant
proteins.
The smallest Erase-a-base clone that contained all of
the htrA gene was used to construct expression plasmids. By
analogy with the E. coli and S. typhimurium HtrA
proteins (22), a putative 26-amino-acid signal sequence was
identified, and the Thr at position 27 was assumed to represent the
start of the mature protein. There is a BspMI site ~72 bp
downstream of the start of the coding sequence for the mature HtrA
protein and a ClaI site downstream of the end of the
htrA gene. Oligonucleotides were synthesized to encode the N
terminus of the mature HtrA protein up to the BspMI site (Fig. 3). Plasmid DNA was digested with
BspMI and ClaI, and the 1.4-kb fragment was
ligated with the NdeI-BspMI oligonucleotides and
vector pT7-7, which had been digested with NdeI and
ClaI, thus generating pT7-7/htrA. For
site-directed mutagenesis, the T7-htrA gene fragment was
cloned into M13mp18 and the Amersham oligonucleotide-directed in vitro
mutagenesis system was used. The T7-htrA mutant genes were
cloned into pT7-7 for expression of the recombinant proteins.
E. coli BL21(DE3) cells were transformed with the
T7-htrA expression plasmids by either the CaCl2
method or electroporation with a Bio-Rad Gene Pulser. The cells were
grown in YT medium to an A578 of 0.3, and
isopropyl-
-D-thiogalactopyranoside (IPTG; Sigma) was
added to 0.4 mM for 2 h. Recombinant proteins were expressed as
soluble proteins and/or inclusion bodies, depending on their mutations.
Purification of recombinant HtrA proteins.
Cells from a
500-ml culture were harvested by centrifugation at 10,000 × g for 10 min at 4°C, and the pellet was resuspended in 40 ml of 50 mM Tris-HCl (pH 8.0) and disrupted by sonication (three times
for 10 min each time). The sonicate was centrifuged at 20,000 × g for 30 min at 4°C, and depending upon the location of
the product, the supernatant or pellet was further purified.
For wild-type rHtrA and the H91A analog, which were expressed as
soluble proteins, the supernatant was applied to a DEAE Sephacel (Pharmacia) column (1 ml of column matrix per 5 ml of extract) equilibrated in 50 mM Tris-HCl (pH 8.0). The majority of rHtrA or H91A
proteins were recovered in the run-through fraction, which was loaded
onto a Macro-prep ceramic hydroxylapatite column (HTP; Bio-Rad
Laboratories) that had the same capacity and that was equilibrated in
10 mM sodium phosphate buffer (pH 8.0). Both rHtrA and H91A proteins
bound to the HTP column. After the column was washed with 175 mM Na
phosphate (pH 8.0), rHtrA or H91A was eluted from the HTP with 0.3 M Na
phosphate (pH 8.0). The amount of rHtrA or H91A in the elution
fractions was determined by the bicinchoninic acid protein assay
(Pierce) using bovine serum albumin as a standard. The purity of rHtrA
or H91A proteins was assessed by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) analysis (19).
Mutant proteins H91R, D121A, D121E, and S197A were expressed as
inclusion bodies, whereas S197C and S197T were expressed partially as
inclusion bodies and partially as soluble proteins. Inclusion bodies
were isolated from the sonicate pellet by extraction with a mixture
containing 40 ml of 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, and 0.5%
Triton X-100. The extract was centrifuged at 20,000 × g for 30 min, and the pellet was solubilized in 10 ml of 50 mM Tris-HCl (pH 8.0) containing 8 M urea. To this solution was added 30 ml of 50 mM Tris-HCl (pH 8.0), and then the solubilized HtrA proteins
were purified by HTP chromatography as described above.
Characterization of wild-type and mutant HtrA proteins.
The
residual serine protease activities of rHtrA and its analogs were
assessed with
-casein as the substrate as described by Lipinska et
al. (22). To study the kinetics of the protease activity, 5 µg of
-casein was mixed with 0.5 µg of HtrA and the mixture was
incubated at 37°C. Aliquots were taken at 10, 20, and 30 min and at
1, 2, 4, and 16 h, and the reaction was stopped immediately by the
addition of SDS-PAGE sample buffer and heating at 100°C for 5 min.
Samples were analyzed by SDS-12.5% PAGE. To determine the residual
protease activities of various analogs, 5 µg of
-casein was mixed
with 0.5 µg of HtrA mutant protein and the mixture was incubated at
37°C for 16 h. Samples were treated and analyzed as described
above.
The effect of protease inhibitors such as Pefabloc SC (Centerchem,
Inc., Stamford, Conn.), phenylmethylsulfonyl fluoride (PMSF; Sigma),
and leupeptin (Sigma) on HtrA activity was determined. Various
concentrations of inhibitors (2.5, 5, and 10 mM concentrations of
Pefabloc SC or PMSF; 100 and 500 mM concentrations of leupeptin) were
added to the
-casein-HtrA reaction mixture, and the samples were
incubated at 37°C for 2 h. Samples were analyzed as described above.
Immunogenicity studies.
To study the immunogenicities of
rHtrA and mutant proteins H91A, D121A, and S197A, groups of five BALB/c
mice (Charles River) were injected subcutaneously (s.c.) on days 1, 29, and 43 with various doses (0.3, 1, 3, and 10 µg) of protein adsorbed
to alum. Blood samples were collected on days 0, 14, 28, 42, and 54.
Anti-HtrA immunoglobulin G (IgG) titers in immune sera were determined
by antigen-specific enzyme-linked immunosorbent assays (ELISAs) as
described by Panezutti et al. (26). Briefly, microtiter wells (Nunc-MAXISORP, Nunc) were coated with 200 ng of rHtrA or mutant
antigen, corresponding to the antibody being tested, for 16 h at
room temperature. The plates were then blocked with 0.1% (wt/vol)
bovine serum albumin (radioimmunoassay grade; Sigma) in
phosphate-buffered saline. The individual sera were serially diluted,
added to the wells, and incubated for 1 h at room temperature. Either affinity-purified F(ab')2 fragments of goat
anti-mouse IgG (Fc-specific) or anti-guinea pig IgG (Fc-specific)
antibodies conjugated to horseradish peroxidase (HRP) (Jackson
ImmunoResearch Laboratories Inc.) were used as the secondary
antibodies. The reactions were developed with
tetramethylbenzidine-hydrogen peroxide, and absorbancies were measured
at 450 nm (with 540 nm as a reference wavelength) in a Flow Multiskan
MCC microplate reader. The reactive titer of an antiserum was defined
as the reciprocal of the dilution consistently showing a twofold
increase in absorbance over that obtained with the prebleed serum
sample.
To determine IgG subclasses, microtiter wells were coated with 200 ng
of purified rHtrA or analog and pooled mouse antisera were used in
ELISAs as described above. Rat anti-mouse IgG1 and IgG2a (Zymed
Laboratories) and IgG2b (Serotec) antibodies, rabbit anti-mouse IgG3
(Zymed Laboratories) antibodies, and donkey anti-rabbit IgG antibodies
conjugated to HRP (Jackson ImmunoResearch Laboratories Inc.) were used
as reagents in the ELISAs. The reactive titers were determined as
described above.
Stress response studies.
Two guinea pigs (Charles River, St.
Constant, Quebec, Canada) were immunized intramuscularly (i.m.) with 10 µg of rHtrA protein emulsified in complete Freund's adjuvant
(Difco). Fourteen and 28 days later, the animals were boosted with the
same amount of immunogen emulsified in incomplete Freund's adjuvant.
Antisera were collected 2 weeks after the last injection.
Hib strain Eagan and E. coli JM109 were grown under various
conditions. Samples were grown to an A578 of 0.3 in BHI or YT medium at 37°C and then were aliquoted and grown in the
same medium at 37, 42, or 43.5°C or in media adjusted to contain 6%
ethanol, 0.2 M NaCl, or 0.3 M NaCl at 37°C. Aliquots were taken at
the following times: 0, 20, 40, 60, and 90 min. They were spun at 16,000 × g for 5 min, and the cell pellets were
resuspended at 40 OD ml
1. One-microliter samples were
analyzed by SDS-PAGE and immunoblotting. Guinea pig antiserum which
recognized both the E. coli and NTHI HtrA proteins was used
to probe immunoblots. Goat anti-guinea pig IgG (Fc-specific) antibody
conjugated to HRP was used as the second antibody, and the blots were
visualized with the LumiGlo chemiluminescent detection system
(Kirkegaard and Perry Laboratories).
Antigenic conservation.
H. influenzae serotypes a, b
(Eagan), c, d, e, and f were grown in BHI medium as described above.
Equivalent concentrations of whole-cell lysates were electrophoresed on
an SDS-11.5% PAGE gel, electroblotted onto a nitrocellulose membrane,
and probed with a 1:1,000 dilution of guinea pig anti-rHtrA antibody.
Fc-specific goat anti-guinea pig IgG antibody conjugated to HRP was
used as the second antibody, and the blot was visualized with the
LumiGlo system.
Protection studies.
Chinchilla protection studies were
performed as described by Barenkamp (2). Briefly, 1- to
2-year-old chinchillas (Moulton Chinchilla Ranch, Rochester, Minn.)
were immunized i.m. with 30 µg of protein adsorbed to alum. Booster
immunizations were given on days 14 and 28, and antisera were collected
2 weeks after the last injection. Negative control animals were mock
immunized with alum by following the same regimen, and positive
controls were convalescent animals that had recovered from previous
infection. Animals were challenged with 50 to 350 CFU of live NTHI
strain 12 or 200 CFU of live LCDC2 through the bulla. Otoscopy and
tympanometry were performed before bacterial inoculation and repeated 4 days postchallenge. Middle ear fluid was collected and immediately mixed with 200 µl of BHI medium. Dilutions of aspirates were made, and 10 µl of undiluted aspirate and 10 µl of 1/10 and 1/100
dilutions were plated onto chocolate agar plates. Bacterial colonies
were counted after 24 h.
Infant rat protection studies were performed as described by Munson and
Granoff (24). Synchronized pregnant Sprague-Dawley rats were
purchased from Harlan Sprague-Dawley (Indianapolis, Ind.). Five-day-old
infant rats were randomized among litters and were injected s.c. in the
dorsal region with 0.1 ml of the antiserum to be tested. Twenty-four
hours later, animals were challenged intraperitoneally with 200 CFU of
freshly grown Hib strain MinnA (0.1 ml). Blood samples were collected
at 20 h postchallenge via cardiac puncture under isoflurane
anesthesia and were plated on chocolate agar plates. Colonies were
counted after one day, and the results were statistically analyzed by
the Fisher exact test. Each study was performed at least twice, and
representative results are shown in Table 3.
Nucleotide sequence accession numbers.
Nucleotide sequences
of NTHI strain 33 htrA and strain 12 htrA have
been deposited in GenBank and have accession no. AF018152 and AF018151,
respectively.
 |
RESULTS |
Cloning and sequence analysis of the htrA gene.
Weinstein et al. had described the derived amino acid sequence of a
47-kDa H. influenzae protein designated Hin47 and the associated nucleotide sequence (36). An oligonucleotide
probe was synthesized based upon the published sequence and the
hin47 gene was cloned from a chromosomal library of NTHI
strain 33. The hin47 gene was localized on the 15.3-kb
chromosomal fragment and sequenced.
The structural gene encodes a protein of 49.2 kDa with a putative
26-amino-acid signal sequence, whose cleavage would result in a
46.4-kDa mature protein. When the hin47 sequence was
compared with sequences in the databases, the gene was found to encode a protein with approximately 54% identity and 69% similarity to the
E. coli and S. typhimurium HtrA proteins (Fig.
4). The E. coli and S. typhimurium proteins are slightly larger than the NTHI protein
(49.3 kDa). (The original published sequence of the E. coli
HtrA protein has been corrected at the carboxy terminus by Waller and
Sauer [35].) The N-terminal ~100 residues of the NTHI protein differ significantly from those of the E. coli
and S. typhimurium HtrA proteins, which are ~89%
identical to each other (16). The htrA gene was
amplified by PCR from NTHI strain 12, and its encoded mature protein
sequence was found to be 99% identical to that of strain 33 HtrA.
These sequences have also been compared to the published H. influenzae Rd HtrA sequence (11), and the three
sequences were found to be 99% identical. In contrast to the E. coli and S. typhimurium HtrA proteins, there are no
cysteine residues in the H. influenzae proteins.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 4.
Sequence alignment of HtrA proteins from NTHI strains 33 and 12, H. influenzae type d strain Rd, E. coli
(Ecoli), and S. typhimurium (Styph). Stop codons are
indicated by asterisks. Dots indicate residues identical to those of
the NTHI strain 33 HtrA, and dashes have been used to achieve maximum
alignment. The residues indicated by arrows are numbered from the
putative Thr start of the mature NTHI HtrA proteins. The main numbering
scheme refers to the full-length encoded protein from the start
methionine of NTHI 33 HtrA. The RGD sequence is underlined in the
strain 33 sequence.
|
|
There is an RGD motif found at the carboxy termini of the E. coli, S. typhimurium, NTHI strain 33, and Rd HtrA
proteins, but in NTHI strain 12, the corresponding sequence is RGN. By
Southern blot analysis, the htrA gene was found in H. influenzae serotype a, b (strain Eagan), c, d, e, and f strains
(data not shown). A fragment encoding the RGD-containing region of HtrA
was amplified by PCR from H. influenzae serotypes a, b
(strain Eagan), c, d, e, and f and four additional NTHI strains. Most
of the strains carried a gene encoding the RGD motif, but 5 of 13 H. influenzae strains contained the RGN motif (data not
shown).
H. influenzae HtrA is a stress response protein.
Since HtrA is known to function as a stress response protein in
E. coli, experiments were performed to determine whether
H. influenzae HtrA was also a stress response protein.
E. coli and Hib strain Eagan were grown in parallel under
standard conditions and under stress-inducing conditions such as high
temperature, 6% ethanol, and high salt concentrations. A guinea pig
antiserum which recognized HtrA from both organisms was used to assess
expression. HtrA was found to be constitutively expressed at low levels
for both organisms under all growth conditions (Fig.
5). At 43.5°C or in the presence of 6%
ethanol, the expression of a second form of HtrA at a slightly higher
apparent molecular weight was induced in both E. coli and
H. influenzae, although the induction was significantly better in the medium containing ethanol. No effect was
observed at 42°C or in the presence of 0.2 or 0.3 M NaCl (results not shown).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 5.
Stress induction of htrA expression. (A)
Immunoblot of E. coli JM109 and Hib strain Eagan grown at
37°C. Lane 1, E. coli at t = 0 min; lane
2, E. coli at t = 20 min; lane 3, E. coli at t = 60 min; lane 4, Hib at
t = 0 min; lane 5, Hib at t = 20 min;
lane 6, Hib at t = 60 min. (B) Immunoblot of E. coli JM109 and Hib strain Eagan grown at 43.5°C. Lane 1, E. coli at t = 0 min; lane 2, E. coli at t = 20 min; lane 3, E. coli at
t = 60 min; lane 4, Hib at t = 0 min;
lane 5, Hib at t = 20 min; lane 6, Hib at
t = 60 min. (C) Immunoblot of E. coli JM109
and Hib strain Eagan grown in the presence of 6% ethanol. Lane 1, E. coli at t = 0 min; lane 2, E. coli at t = 20 min; lane 3, E. coli at
t = 60 min; lane 4, Hib at t = 0 min;
lane 5, Hib at t = 20 min; lane 6, Hib at
t = 60 min. In all panels, the numbers at the left
represent molecular weights in thousands.
|
|
H. influenzae HtrA has serine protease activity.
The effect of protease inhibitors on rHtrA activity was determined. It
was found that two serine protease inhibitors, Pefabloc SC and PMSF,
completely inhibited the rHtrA activity at concentrations of 10 mM. In
contrast, the thiol protease inhibitor leupeptin did not show any
effect even at 500 mM, a concentration which is 250 times higher than
that routinely used (27).
Identification of active-site residues.
The consensus sequence
surrounding the active-site serine of serine proteases is GDSGGPK
(6), where the serine is the active-site nucleophile. An
examination of the strain 33 HtrA sequence revealed a GNSGGAL motif
around Ser197 (numbered from the proposed Thr1 residue). By comparison
with other bacterial and mammalian serine proteases, the other members
of the catalytic triad were predicted to be His91 and Asp121. Figure
6 shows the alignment of NTHI HtrA with
the sequences of serine proteases from the Protein Data Bank.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 6.
Identification of HtrA active-site residues. Multiple
sequence alignment of the serine protease domain of NTHI HtrA (residues
57 to 256) with serine proteases from the Protein Data Bank (PDB).
Arrows denote the catalytic triad residues. Protease sequences obtained
from PDB entries are as follows: TON, pdb1ton.ent (rat tonin); PKA,
pdb2pka.ent (porcine kallikrein A); PTN, pdb2ptn.ent (bovine trypsin);
CHA, pdb4cha.ent (bovine chymotrypsin); EST, pdb3est.ent (porcine
elastase); RP2, pdb3rp2.ent (rat mast cell protease II); SGT,
pdb1sgt.ent (Streptomyces griseus trypsin); SGB, pdb3sgb.ent
(S. griseus proteinase B); SGA, pdb2sga.ent (S. griseus proteinase A); ALP, pdb2alp.ent (L. enzymogenes
alpha-lytic protease).
|
|
Expression and characterization of recombinant HtrA and
mutants.
The strain 33 htrA gene was cloned behind the
inducible T7 promoter in vector pT7-7 (33), and the
recombinant protein was produced at high levels in E. coli
BL21(DE3) cells. Nine HtrA analogs were generated at the His91, Asp121,
or Ser197 residues of the catalytic triad, and all of the mutant HtrA
proteins were expressed at a very high yield (~40 to 50% of total
protein) from E. coli. The recombinant proteins were
expressed as soluble proteins (wild type and H91A), inclusion bodies
(H91R, D121A, D121E, S197A, H91A/S197A, and H91A/D121A/S197A), or a
mixture of both forms (S197C and S197T), and all were readily purified
(Fig. 7).

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 7.
SDS-PAGE analysis of rHtrA and analogs during
purification performed on 12.5% polyacrylamide gels. Lanes 1, prestained molecular weight markers; lanes 2, total cellular proteins
from E. coli BL21(DE3) expressing rHtrA or mutant proteins;
lanes 3, crude extract of recombinant protein; lanes 4, flowthrough
fraction from DEAE Sephacel column for soluble rHtrA and H91A; lanes 5, purified protein after the HTP column. The numbers at the left of each
row represent molecular weights in thousands.
|
|
The protease activity of rHtrA was determined as described by Lipinska
et al. (22), with
-casein as a substrate. As shown in
Fig. 8A, digestion of casein by rHtrA was
noticeable after 30 min of incubation (lane 5) and was complete after
16 h (lane 9). By the same assay, it was found that of the nine
HtrA analogs, only D121E exhibited protease activity under these
conditions (Fig. 8B, lane 10). Although the amount of rHtrA or analogs
added to the reaction mixtures was approximately 0.5 µg, the SDS-PAGE analysis in Fig. 8B suggests that some of the analogs may actually have
been present at higher concentrations and still did not show appreciable degradation of
-casein.

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 8.
Protease activity of rHtrA and its analogs. (A)
Wild-type rHtrA (0.5 µg) was mixed with -casein (5 µg) and
incubated at 37°C. Samples were taken at various time points and
analyzed by SDS-PAGE. Lane 1, molecular weight standards; lane 2, t = 0 min; lane 3, t = 10 min; lane 4, t = 20 min; lane 5, t = 30 min; lane 6, t = 1 h; lane 7, t = 2 h;
lane 8, t = 4 h; lane 9, t = 16 h; lane 10, no HtrA added at t = 16 h. (B) Wild-type rHtrA or its analogs (0.5 µg) were mixed with
-casein (5 µg) and incubated at 37°C for 16 h. Lane 1, molecular weight standards; lane 2, casein alone; lane 3, rHtrA; lane
4, S197A; lane 5, S197C; lane 6, S197T; lane 7, H91A; lane 8, H91R;
lane 9, D121A; lane 10, D121E. For both panels, the numbers at the left
represent molecular weights in thousands.
|
|
Immunogenicity and protection studies.
Purified rHtrA, H91A,
D121A, and S197A were used to immunize BALB/c mice, and after three
immunizations, all four proteins were found to be very immunogenic at
doses as low as 0.3 µg when administered in alum (Table
1). The antibody isotype profiles were
determined for rHtrA, H91A, and S197A and were found to be equivalent
for the three proteins, with a dominant IgG1 response (Table
2). Guinea pig anti-NTHI rHtrA recognized
putative HtrA from H. influenzae serotype a, b, c, d, e, and
f strains, although the reactivity with serotype f was very weak (Fig.
9).

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 9.
Antigenic conservation of HtrA in H. influenzae strains. Lane 1, serotype a; lane 2, serotype b
(Eagan); lane 3, serotype c; lane 4, serotype d; lane 5, serotype e;
lane 6, serotype f. Guinea pig anti-NTHI rHtrA was used to probe the
blots. The numbers at the left represent molecular weights in
thousands.
|
|
Chinchillas were immunized three times with purified strain 33-derived
rHtrA, H91A, or S197A. Negative controls were immunized with alum, and
positive controls were convalescent animals that had recovered from
previous middle ear infection with the homologous strain. Intrabullar
challenge with live NTHI strain 33 resulted in unacceptable morbidity,
so animals were challenged with the heterologous NTHI strain 12 or
LCDC2. All convalescent animals were protected against challenge (data
not shown), whereas the majority (75 to 83%) of mock-immunized
negative control animals were infected (Fig.
10). Four of five animals immunized
with rHtrA and challenged with strain 12 were protected (Fig. 10A).
Immunization with H91A conferred partial protection (~50%) against
challenge with either NTHI strain 12 or strain LCDC2 (Fig. 10B and C).
However, no protection was observed in animals immunized with S197A
(Fig. 10B).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 10.
Protection studies in the chinchilla intrabulla
challenge model of otitis media. Chinchillas (1 to 2 years old) were
immunized three times (i.m.) with 30 µg of antigen adsorbed to alum.
Two weeks after the last injection, animals were challenged with live
NTHI strain 12 (50 to 350 CFU) (A and B) or LCDC2 (200 CFU) (C) through
the epitympanic bulla. Middle ear fluid was collected 4 days
postchallenge. Each data point represents the bacteria recovered from a
single chinchilla.
|
|
Chinchilla anti-rHtrA, anti-H91A, and anti-S197A antisera, obtained as
described above, were used to passively immunize infant rats. Positive
and negative control sera were antisera raised against heat-inactivated
Hib strain MinnA and prebleed sera, respectively. Animals were
challenged with live Hib strain MinnA. All of the HtrA-specific immune
sera were partially protective in this model, with 6 of 10 animals
exhibiting no or very low-level bacteremia (Table
3).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Protective effect of passively transferred chinchilla
antiserum against Hib challenge in the infant rat model
of bacteremiaa
|
|
 |
DISCUSSION |
The sequences of the NTHI HtrA proteins and the Rd HtrA (HI1259)
sequence (11) were found to be highly conserved, with
differences at only five positions among the strains. One of these
amino acid changes is in an Arg-Gly-Asp (RGD) motif found at the
carboxy terminus of HtrA. The RGD motif has been identified as a cell attachment site for mammalian adhesion proteins (28). Of the 13 H. influenzae htrA genes that we studied, five encoded an
RGN motif and the rest encoded RGD. E. coli expresses two
homologs of HtrA (or DegP), which are called DegQ (HhoA) and DegS
(HhoB) (3, 35). The DegP and DegQ proteins have 60%
identical and 75% similar sequences and are serine proteases. One
noticeable sequence difference is that DegP contains an RGD sequence
and DegQ contains an RGN sequence (35). In a recent paper by
Li et al. (20), an alignment of the HtrA proteins from
Y. enterocolitica, S. typhimurium, E. coli, B. abortus, Rochalimaea hensalae,
Helicobacter pylori, and Campylobacter jejuni
demonstrated that only the first three of these organisms contain the
carboxy-terminal RGD sequence. Since HtrA is a periplasmic protein, it
is unclear what function the RGD or RGN sequence might play, but the
fact that it is at least semiconserved among different species is
intriguing. In addition, if it is surface expressed under stress
conditions, the RGD sequence may play an attachment function.
The E. coli HtrA protein has been shown to be inducible by
temperatures of >42°C, but the S. typhimurium HtrA
protein is not temperature inducible (16). By immunoblot
analysis, we demonstrated low-level constitutive expression of HtrA in
both E. coli and H. influenzae under normal
culture conditions, with an increased expression of a slightly larger
protein under stress conditions. The amount of protein expressed was
too small to allow N-terminal sequence determination, so we can only
speculate as to the nature of the second protein. It is possible that
it is the unprocessed precursor protein or a conformational variant of
HtrA, although the latter possibility seems unlikely based upon the
results of Skorko-Glonek et al. (32), who showed that
E. coli HtrA was relatively thermostable up to 70°C. Since
DegQ is not heat inducible, the second protein band is not likely to be
DegQ (35).
The proteolytic activity of H. influenzae rHtrA was blocked
by serine protease inhibitors, indicating that like the E. coli HtrA, it is a serine protease. Alignment of the NTHI,
E. coli, and S. typhimurium HtrA protein
sequences showed that there is a consensus sequence of GNSGGAL
surrounding the putative Ser197 active-site residue. With alignments
anchored on this residue, the other residues of the catalytic triad
were identified from alignments with other bacterial and mammalian
serine proteases of known structure. In general, bacterial trypsin-like
serine proteases such as alpha-lytic protease from Lysobacter
enzymogenes and proteases A and B from Streptomyces
griseus are significantly smaller than mammalian ones
(4). However, because the active sites and cores of these
proteases can be reliably aligned to mammalian serine proteases, they
provide an indication of where sequence variability, including the
locations of insertions and deletions, can be expected (12,
13). Thus, the active-site histidine could be assigned to His91
of NTHI HtrA despite the presence of only a low level of local sequence
homology and the absence of a conserved disulfide bond immediately
following this residue. Asp121 was assigned on the basis of its local
sequence alignment with a combination of identical or similar residues in other proteases. To confirm these residues, a three-dimensional model of the HtrA site was constructed by using L. enzymogenes alpha-lytic protease as a template (12) and
various serine protease structures from the Protein Data Bank
(5). The catalytic triad could be readily accommodated
within this model in comparison to the crystal structures of mammalian
and bacterial serine proteases. Using site-directed mutagenesis,
Skorko-Glonek et al. (31) demonstrated that the Ser210 and
His105 residues of the mature E. coli HtrA protein were part
of the catalytic triad. The serine residue was identified by the
homology of the sequences of the surrounding amino acids to the
consensus sequence for serine proteases, and there is only one
histidine residue in the molecule. Li et al. (20) and Waller
and Sauer (35) predicted that the Asp136 residue of E. coli HtrA is part of the catalytic residue, a prediction which
correlates very well with our finding of Asp121 in the NTHI proteins.
Mutations of the His91, Asp121, and Ser197 codons were found to abolish
the protease activity. The D121E analog still retained its enzymatic
activity, although D121A did not, suggesting that the negative charge
is important for activity.
The assignment of the catalytic triad residues provided a basis for
delineating the boundaries of the protease domain, which comprises
about 45% of the HtrA sequence, i.e., between residues 54 and 255. The
rHtrA protein was found to contain a major degradation product that
started with residue Asp54. By homology with other proteases, residues
1 to 53 may be cleaved from a zymogen form of HtrA in order for it to
become active. E. coli cells overproducing wild-type
recombinant E. coli HtrA were found to contain two major ~43-kDa HtrA degradation products, beginning at Cys69 and Gln82 (31). It was speculated that these products were
autocatalytic in nature since the mutant HtrA proteins did not contain
them.
Antisera raised to NTHI strain 33-derived rHtrA, H91A, or S197A were
all equally protective in the passive infant rat model of bacteremia
(24), wherein 6 of 10 animals had no or minimal bacteremia.
These data indicated that the three proteins were inducing functional
antibodies. In this model, the animals are challenged with live Hib
organisms, and the partial protection demonstrates that the anti-NTHI
rHtrA antibodies recognize the HtrA protein in Hib. Immunoblot
analysis showed that anti-NTHI rHtrA antisera recognize ~46-kDa
proteins in H. influenzae serotypes a, b, c, d, e, and f
(weak), demonstrating the antigenic conservation of the HtrA proteins.
In the chinchilla model of otitis media, animals were immunized with
NTHI strain 33-derived rHtrA or its H91A or S197A analogs and were
challenged with live NTHI strain 12 or LCDC2 organisms. The rHtrA and
H91A proteins induced partial protection, but the S197A protein was not
protective. The IgG subtype profiles elicited by immunization with the
three immunogens were determined with mice, and it was found that all
three were identical, with a predominant IgG1 response, a small IgG2b
response, and no IgG2a or IgG3 response. One explanation for the
observed difference in protection between H91A and S197A could be that they have different conformations after purification as soluble or
inclusion body-derived proteins; however, we were unable to demonstrate
any difference by circular dichroism analysis (data not shown). It is
also unclear why this difference is evident only in the chinchilla
model and not the infant rat model.
The exact role of the HtrA protein in the pathogenesis of H. influenzae remains to be determined; however, if HtrA serves as a
target for bactericidal antibodies or opsonic activity, it must be
accessible to antibodies. Since HtrA is an apparently periplasmic
protein, it is not evident how such antigen-antibody interactions can
occur. It is possible that during infection, some surface expression of
HtrA is induced as part of a stress response mechanism, e.g., fever.
Other intracellular Hsps have been shown to become surface expressed
under physiological stress conditions and have been implicated as
adhesion factors (9, 10, 15).
In these studies, we have cloned, sequenced, and expressed the NTHI
htrA gene and have shown that the H. influenzae
HtrA protein has serine protease activity. This activity can be
abolished by site-directed mutagenesis of the htrA gene, and
the resultant H91A and S197A HtrA analogs induce antibodies which are
partially protective in a passive model of bacteremia. In the
chinchilla model of otitis media, H91A was also partially protective,
indicating that this antigen may be suitable for inclusion in a
multicomponent otitis media vaccine. A phase I clinical trial of the
H91A HtrA protein is in progress.
 |
ACKNOWLEDGMENTS |
We thank Bill Bradley for synthesis of oligonucleotides and Diane
England for DNA sequencing. M. Haer, D. Persaud, and W. Xu-Li are
acknowledged for their excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Pasteur Merieux
Connaught Canada Research, 1755 Steeles Ave. W., North York, Ontario, Canada M2R 3T4. Phone: (416) 667-2932. Fax: (416) 667-2740. E-mail:sloosmore{at}ca.pmc-vacc.com.
Editor: J. G. Cannon
 |
REFERENCES |
| 1.
|
Barbour, M. L.,
R. T. Mayon-White,
C. Coles,
D. W. M. Crook, and E. R. Moxon.
1995.
The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.
J. Infect. Dis.
171:93-98[Medline].
|
| 2.
|
Barenkamp, S.
1986.
Protection by serum antibodies in experimental nontypable [sic] Haemophilus influenzae otitis media.
Infect. Immun.
52:572-578[Abstract/Free Full Text].
|
| 3.
|
Bass, S.,
Q. Gu, and A. Christen.
1996.
Multicopy suppressors of Prc mutant Escherichia coli include two HtrA (DegP) protease homologs (HhoAB), DskA, and a truncated RlpA.
J. Bacteriol.
178:1154-1161[Abstract/Free Full Text].
|
| 4.
|
Bazan, J. F., and R. J. Fletterick.
1990.
Structural and catalytic models of trypsin-like viral proteases.
Semin. Virol.
1:311-322.
|
| 5.
|
Bernstein, F. C.,
T. F. Koetzle,
G. J. B. Williams,
E. F. Meyer, Jr.,
M. D. Brice,
J. R. Rodgers,
O. Kennard,
T. Shimanouchi, and M. Tasumi.
1977.
The Protein Data Bank: a computer-based archival file for macromolecular structures.
J. Mol. Biol.
112:535-542[Medline].
|
| 6.
|
Brenner, S.
1988.
The molecular evolution of genes and proteins: a tale of two serines.
Nature
334:528-530[Medline].
|
| 7.
|
Chuang, S.-E., and F. R. Blattner.
1993.
Characterization of twenty-six new heat shock genes of Escherichia coli.
J. Bacteriol.
175:5242-5252[Abstract/Free Full Text].
|
| 8.
|
Elzer, P. H.,
R. W. Phillips,
G. T. Robertson, and R. M. Roop, II.
1996.
The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes.
Infect. Immun.
64:4838-4841[Abstract].
|
| 9.
|
Ensgraber, M., and M. Loos.
1992.
A 66-kilodalton heat shock protein of Salmonella typhimurium is responsible for binding of the bacterium to intestinal mucus.
Infect. Immun.
60:3072-3078[Abstract/Free Full Text].
|
| 10.
|
Evans, D. J., Jr.,
D. G. Evans,
L. Engstrand, and D. Y. Graham.
1992.
Urease-associated heat shock protein of Helicobacter pylori.
Infect. Immun.
60:2125-2127[Abstract/Free Full Text].
|
| 11.
|
Fleischmann, R. D.,
M. D. Adams,
O. White,
R. A. Clayton,
E. F. Kirkness,
A. R. Kerlavage,
C. J. Bult,
J.-F. Tomb,
B. A. Dougherty,
J. M. Merrick,
K. McKenney,
G. Sutton,
W. FitzHugh,
C. Fields,
J. D. Gocayne,
J. Scott,
R. Shirley,
L.-I. Liu,
A. Glodek,
J. M. Kelley,
J. F. Weidman,
C. A. Phillips,
T. Spriggs,
E. Hedblom,
M. D. Cotton,
T. R. Utterback,
M. C. Hanna,
D. T. Nguyen,
D. M. Saudek,
R. C. Brandon,
L. D. Fine,
J. L. Fritchman,
J. L. Fuhrmann,
N. S. M. Geoghagen,
C. L. Gnehm,
L. A. McDonald,
K. V. Small,
C. M. Fraser,
H. O. Smith, and J. C. Venter.
1995.
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd.
Science
269:496-512[Abstract/Free Full Text].
|
| 12.
|
Fujinaga, M.,
L. T. J. Delbaere,
G. D. Brayer, and M. N. G. James.
1985.
Refined crystal structure of -lytic protease at 1.7 Å resolution.
J. Mol. Biol.
183:479-502[Medline].
|
| 13.
|
Greer, J.
1990.
Comparative molecular modeling methods: application to the family of the mammalian serine proteases.
Proteins
7:317-334[Medline].
|
| 14.
|
Harkness, R. E.,
P. Chong, and M. H. Klein.
1992.
Identification of two iron-repressed periplasmic proteins in Haemophilus influenzae.
J. Bacteriol.
174:2425-2430[Abstract/Free Full Text].
|
| 15.
|
Hartmann, E., and C. Lingwood.
1997.
Brief heat shock treatment induces a long-lasting alteration in the glycolipid receptor binding specificity and growth rate of Haemophilus influenzae.
Infect. Immun.
65:1729-1733[Abstract].
|
| 16.
|
Johnson, K.,
I. Charles,
G. Dougan,
D. Pickard,
P. O'Gaora,
G. Costa,
T. Ali,
I. Miller, and C. Hormaeche.
1991.
The role of a stress-response protein in Salmonella typhimurium virulence.
Mol. Microbiol.
5:401-407[Medline].
|
| 17.
|
Klein, J. O.
1994.
Lessons from recent studies on the epidemiology of otitis media.
Pediatr. Infect. Dis. J.
13:1031-1034[Medline].
|
| 18.
|
Kroll, J. S.,
R. Moxon, and B. M. Loynds.
1994.
Natural genetic transfer of a putative virulence-enhancing mutation to Haemophilus influenzae type a.
J. Infect. Dis.
169:676-679[Medline].
|
| 19.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 20.
|
Li, S.-R.,
N. Dorrell,
P. H. Everest,
G. Dougan, and B. W. Wren.
1996.
Construction and characterization of a Yersinia enterocolitica O:8 high-temperature requirement (htrA) isogenic mutant.
Infect. Immun.
64:2088-2094[Abstract].
|
| 21.
|
Lipinska, B.,
O. Fayet,
L. Baird, and C. Georgopoulos.
1989.
Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures.
J. Bacteriol.
171:1574-1584[Abstract/Free Full Text].
|
| 22.
|
Lipinska, B.,
M. Zylicz, and C. Georgopoulos.
1990.
The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase.
J. Bacteriol.
172:1791-1797[Abstract/Free Full Text].
|
| 23.
|
Loosmore, S. M.,
Y.-P. Yang,
D. C. Coleman,
J. M. Shortreed,
D. M. England,
R. E. Harkness,
P. S.-C. Chong, and M. H. Klein.
1996.
Cloning and expression of the Haemophilus influenzae transferrin receptor genes.
Mol. Microbiol.
19:575-586[Medline].
|
| 24.
|
Munson, R. S., Jr., and D. M. Granoff.
1985.
Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b.
Infect. Immun.
49:544-549[Abstract/Free Full Text].
|
| 25.
|
Nitta, D. M.,
M. A. Jackson,
V. F. Burry, and L. C. Olson.
1995.
Invasive Haemophilus influenzae type f disease.
Pediatr. Infect. Dis. J.
14:157-160[Medline].
|
| 26.
|
Panezutti, H.,
O. James,
E. J. Hanson,
Y. Choi,
R. E. Harkness,
M. H. Klein, and P. Chong.
1993.
Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies.
Infect. Immun.
61:1867-1872[Abstract/Free Full Text].
|
| 27.
|
Pohl, T.
1990.
Concentration of proteins and removal of solutes.
Methods Enzymol.
182:68-89[Medline].
|
| 28.
|
Ruoslahti, E., and M. D. Pierschbacher.
1986.
Arg-Gly-Asp: a versatile cell recognition signal.
Cell
44:517-518[Medline].
|
| 29.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 30.
|
Schoendorf, K. C.,
W. G. Adams,
J. L. Kiely, and J. D. Wenger.
1994.
National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980-1991.
Pediatrics
93:663-668[Abstract/Free Full Text].
|
| 31.
|
Skorko-Glonek, J.,
A. Wawrzynow,
K. Krzewski,
K. Kurpierz, and B. Lipinska.
1995.
Site-directed mutagenesis of the HtrA (DegP) serine protease, whose proteolytic activity is indispensable for Escherichia coli survival at elevated temperatures.
Gene
163:47-52[Medline].
|
| 32.
|
Skorko-Glonek, J.,
K. Krzewski,
B. Lipinska,
E. Bertoli, and F. Tanfani.
1995.
Comparison of the structure of wild-type HtrA heat shock protease and mutant HtrA proteins.
J. Biol. Chem.
270:11140-11146[Abstract/Free Full Text].
|
| 33.
|
Tabor, S., and C. C. Richardson.
1985.
A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.
Proc. Natl. Acad. Sci. USA
82:1074-1078[Abstract/Free Full Text].
|
| 34.
|
Waggoner-Fountain, L. A.,
J. O. Hendley,
E. J. Cody,
V. A. Perriello, and L. G. Donowitz.
1995.
The emergence of Haemophilus influenzae types e and f as significant pathogens.
Clin. Infect. Dis.
21:1322-1324[Medline].
|
| 35.
|
Waller, P. R. H., and R. T. Sauer.
1996.
Characterization of degQ and degS, Escherichia coli genes encoding homologs of the DegP protease.
J. Bacteriol.
178:1146-1153[Abstract/Free Full Text].
|
| 36.
|
Weinstein, D. L.,
S. M. Turkovski,
C. F. Kerry,
H. C. Krivan, and J. E. Samuel.
1992.
Cloning and characterization of an [sic] Haemophilus influenzae type b adhesin, abstr. D-243, p. 136.
Abstracts of the 92nd General Meeting of the American Society for Microbiology 1992.
American Society for Microbiology, Washington, D.C.
|
| 37.
|
Wishart, D. S.,
R. F. Boyko, and B. D. Sykes.
1994.
Constrained multiple sequence alignment using XALIGN.
Comput. Appl. Biosci.
10:687-688[Free Full Text].
|
Infect Immun, March 1998, p. 899-906, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chitlaru, T., Gat, O., Grosfeld, H., Inbar, I., Gozlan, Y., Shafferman, A.
(2007). Identification of In Vivo-Expressed Immunogenic Proteins by Serological Proteome Analysis of the Bacillus anthracis Secretome. Infect. Immun.
75: 2841-2852
[Abstract]
[Full Text]
-
Winter, L. E., Barenkamp, S. J.
(2006). Antibodies Specific for the High-Molecular-Weight Adhesion Proteins of Nontypeable Haemophilus influenzae Are Opsonophagocytic for both Homologous and Heterologous Strains. CVI
13: 1333-1342
[Abstract]
[Full Text]
-
Gat, O., Grosfeld, H., Ariel, N., Inbar, I., Zaide, G., Broder, Y., Zvi, A., Chitlaru, T., Altboum, Z., Stein, D., Cohen, S., Shafferman, A.
(2006). Search for Bacillus anthracis Potential Vaccine Candidates by a Functional Genomic-Serologic Screen. Infect. Immun.
74: 3987-4001
[Abstract]
[Full Text]
-
Chitlaru, T., Gat, O., Gozlan, Y., Ariel, N., Shafferman, A.
(2006). Differential Proteomic Analysis of the Bacillus anthracis Secretome: Distinct Plasmid and Chromosome CO2-Dependent Cross Talk Mechanisms Modulate Extracellular Proteolytic Activities.. J. Bacteriol.
188: 3551-3571
[Abstract]
[Full Text]
-
Alonso, S., Willery, E., Renauld-Mongenie, G., Locht, C.
(2005). Production of Nontypeable Haemophilus influenzae HtrA by Recombinant Bordetella pertussis with the Use of Filamentous Hemagglutinin as a Carrier. Infect. Immun.
73: 4295-4301
[Abstract]
[Full Text]
-
Wonderling, L. D., Wilkinson, B. J., Bayles, D. O.
(2004). The htrA (degP) Gene of Listeria monocytogenes 10403S Is Essential for Optimal Growth under Stress Conditions. Appl. Environ. Microbiol.
70: 1935-1943
[Abstract]
[Full Text]
-
Winter, L. E., Barenkamp, S. J.
(2003). Human Antibodies Specific for the High-Molecular-Weight Adhesion Proteins of Nontypeable Haemophilus influenzae Mediate Opsonophagocytic Activity. Infect. Immun.
71: 6884-6891
[Abstract]
[Full Text]
-
Kyd, J. M., Cripps, A. W., Novotny, L. A., Bakaletz, L. O.
(2003). Efficacy of the 26-Kilodalton Outer Membrane Protein and Two P5 Fimbrin-Derived Immunogens To Induce Clearance of Nontypeable Haemophilus influenzae from the Rat Middle Ear and Lungs as Well as from the Chinchilla Middle Ear and Nasopharynx. Infect. Immun.
71: 4691-4699
[Abstract]
[Full Text]
-
Bumann, D., Aksu, S., Wendland, M., Janek, K., Zimny-Arndt, U., Sabarth, N., Meyer, T. F., Jungblut, P. R.
(2002). Proteome Analysis of Secreted Proteins of the Gastric Pathogen Helicobacter pylori. Infect. Immun.
70: 3396-3403
[Abstract]
[Full Text]
-
Montigiani, S., Falugi, F., Scarselli, M., Finco, O., Petracca, R., Galli, G., Mariani, M., Manetti, R., Agnusdei, M., Cevenini, R., Donati, M., Nogarotto, R., Norais, N., Garaguso, I., Nuti, S., Saletti, G., Rosa, D., Ratti, G., Grandi, G.
(2002). Genomic Approach for Analysis of Surface Proteins in Chlamydia pneumoniae. Infect. Immun.
70: 368-379
[Abstract]
[Full Text]
-
Sethi, S., Murphy, T. F.
(2001). Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review. Clin. Microbiol. Rev.
14: 336-363
[Abstract]
[Full Text]
-
Bakaletz, L. O., Kennedy, B.-J., Novotny, L. A., Duquesne, G., Cohen, J., Lobet, Y.
(1999). Protection against Development of Otitis Media Induced by Nontypeable Haemophilus influenzae by Both Active and Passive Immunization in a Chinchilla Model of Virus-Bacterium Superinfection. Infect. Immun.
67: 2746-2762
[Abstract]
[Full Text]